Radboud University Medical Center
🇳🇱Netherlands
- Country
- 🇳🇱Netherlands
- Ownership
- Private
- Established
- 1951-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.radboudumc.nl
CD8+ T-cell PET/CT Imaging in COVID-19 Patients
- Conditions
- Interventions
- First Posted Date
- 2021-05-06
- Last Posted Date
- 2022-06-07
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT04874818
- Locations
- 🇳🇱
Radboud university medical center, Nijmegen, Gelderland, Netherlands
Cemiplimab for Secondary Angiosarcomas
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-05-05
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 18
- Registration Number
- NCT04873375
- Locations
- 🇳🇱
RadboudUMC, Nijmegen, Netherlands
Safety and Efficacy of R0.6C Vaccine
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-04-28
- Last Posted Date
- 2022-07-07
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 32
- Registration Number
- NCT04862416
- Locations
- 🇳🇱
Radboud university medical center, Nijmegen, Gelderland, Netherlands
STEPWISE Parkinson: A Smartphone Based Exercise Solution for Patients With Parkinson's Disease
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-04-19
- Last Posted Date
- 2023-02-24
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 452
- Registration Number
- NCT04848077
- Locations
- 🇳🇱
Radboud university medical center, Nijmegen, Gelderland, Netherlands
Safety and Tolerability of COVID-19 Vaccine (ABNCoV2)
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-04-09
- Last Posted Date
- 2024-02-12
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 45
- Registration Number
- NCT04839146
- Locations
- 🇳🇱
Radboud univserity medical center, Nijmegen, Gelderland, Netherlands
Studying Anakinra to Reduce Secondary Brain Damage After Spontaneous Haemorrhagic Stroke
- First Posted Date
- 2021-04-08
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 75
- Registration Number
- NCT04834388
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Netherlands
Real World Pharmacokinetics of Immune Checkpoint Inhibitors
- First Posted Date
- 2021-04-06
- Last Posted Date
- 2023-05-31
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 19
- Registration Number
- NCT04833075
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands
Characterizing Rate of Progression in USHer Syndrome (CRUSH) Study
- Conditions
- Interventions
- First Posted Date
- 2021-03-29
- Last Posted Date
- 2022-04-29
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 36
- Registration Number
- NCT04820244
- Locations
- 🇳🇱
Radboud universitair medisch centrum, Nijmegen, Gelderland, Netherlands
Breast Cancer Patients' Cognitive Symptoms After Information About Chemotherapy-Related Cognitive Symptoms
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-03-24
- Last Posted Date
- 2021-03-24
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 148
- Registration Number
- NCT04813965
SPIO-enhanced MRI in Oral Cancer for Sentinel Lymph Node Identification
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2021-03-17
- Last Posted Date
- 2022-10-26
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT04803331
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands
© Copyright 2024. All Rights Reserved by MedPath